These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7495214)

  • 1. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.
    Motz W; Vogt M; Scheler S; Strauer BE
    Eur Heart J; 1992 Sep; 13 Suppl D():100-6. PubMed ID: 1396852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):48D-53D. PubMed ID: 7495218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications.
    Motz W; Vogt M; Strauer BE
    Clin Investig; 1993; 71(5 Suppl):S42-5. PubMed ID: 8518540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ protection: benefit from antihypertensive treatment?
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve.
    Strauer BE; Schwartzkopff B
    Am J Hypertens; 1998 Jul; 11(7):879-81. PubMed ID: 9683053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodelling of intramyocardial arterioles and extracellular matrix in patients with arterial hypertension and impaired coronary reserve.
    Schwartzkopff B; Mundhenke M; Strauer BE
    Eur Heart J; 1995 Aug; 16 Suppl I():82-6. PubMed ID: 8829962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].
    Vogt M; Motz W; Strauer BE
    Arzneimittelforschung; 1994 Dec; 44(12):1321-8. PubMed ID: 7848351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach].
    Anguita Sánchez M
    Rev Esp Cardiol; 1999; 52 Suppl 3():34-8. PubMed ID: 10614147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium antagonists on left ventricular structure and function.
    Betocchi S; Chiariello M
    J Hypertens Suppl; 1993 Mar; 11(1):S33-7. PubMed ID: 8483020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W; Scheler S; Strauer BE
    Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication.
    Yoshida C; Goda A; Naito Y; Nakaboh A; Matsumoto M; Otsuka M; Ohyanagi M; Hirotani S; Lee-Kawabata M; Tsujino T; Masuyama T
    J Hypertens; 2011 Feb; 29(2):357-63. PubMed ID: 21052021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.